200 related articles for article (PubMed ID: 17604594)
1. The use of human cell line reporter gene-based assays in chemical toxicity testing.
Scrivens M; Bhogal N
Toxicol In Vitro; 2007 Oct; 21(7):1233-40. PubMed ID: 17604594
[TBL] [Abstract][Full Text] [Related]
2. Alternatives to the carcinogenicity bioassay: in silico methods, and the in vitro and in vivo mutagenicity assays.
Benigni R; Bossa C; Tcheremenskaia O; Giuliani A
Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):809-19. PubMed ID: 20438313
[TBL] [Abstract][Full Text] [Related]
3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
4. In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results.
Kirkland DJ; Aardema M; Banduhn N; Carmichael P; Fautz R; Meunier JR; Pfuhler S
Mutagenesis; 2007 May; 22(3):161-75. PubMed ID: 17369606
[TBL] [Abstract][Full Text] [Related]
5. Glyphosate-based herbicides are toxic and endocrine disruptors in human cell lines.
Gasnier C; Dumont C; Benachour N; Clair E; Chagnon MC; Séralini GE
Toxicology; 2009 Aug; 262(3):184-91. PubMed ID: 19539684
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast chemicals.
Knight AW; Little S; Houck K; Dix D; Judson R; Richard A; McCarroll N; Akerman G; Yang C; Birrell L; Walmsley RM
Regul Toxicol Pharmacol; 2009 Nov; 55(2):188-99. PubMed ID: 19591892
[TBL] [Abstract][Full Text] [Related]
7. Genetic toxicity assessment: employing the best science for human safety evaluation part III: the comet assay as an alternative to in vitro clastogenicity tests for early drug candidate selection.
Witte I; Plappert U; de Wall H; Hartmann A
Toxicol Sci; 2007 May; 97(1):21-6. PubMed ID: 17204584
[TBL] [Abstract][Full Text] [Related]
8. Determination of genetic toxicity and potential carcinogenicity in vitro--challenges post the Seventh Amendment to the European Cosmetics Directive.
Tweats DJ; Scott AD; Westmoreland C; Carmichael PL
Mutagenesis; 2007 Jan; 22(1):5-13. PubMed ID: 17142828
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo.
Kirkland D; Speit G
Mutat Res; 2008 Jul; 654(2):114-32. PubMed ID: 18585956
[TBL] [Abstract][Full Text] [Related]
10. Preclinical testing for teratogenicity and developmental toxicity: methods and limitations.
Barrow PC
Therapie; 2002; 57(2):109-14. PubMed ID: 12185956
[TBL] [Abstract][Full Text] [Related]
11. High-specificity and high-sensitivity genotoxicity assessment in a human cell line: validation of the GreenScreen HC GADD45a-GFP genotoxicity assay.
Hastwell PW; Chai LL; Roberts KJ; Webster TW; Harvey JS; Rees RW; Walmsley RM
Mutat Res; 2006 Sep; 607(2):160-75. PubMed ID: 16781187
[TBL] [Abstract][Full Text] [Related]
12. An assessment of the utility of the yeast GreenScreen assay in pharmaceutical screening.
Van Gompel J; Woestenborghs F; Beerens D; Mackie C; Cahill PA; Knight AW; Billinton N; Tweats DJ; Walmsley RM
Mutagenesis; 2005 Nov; 20(6):449-54. PubMed ID: 16291732
[TBL] [Abstract][Full Text] [Related]
13. Opportunities for an alternative integrating testing strategy for carcinogen hazard assessment?
Doktorova TY; Pauwels M; Vinken M; Vanhaecke T; Rogiers V
Crit Rev Toxicol; 2012 Feb; 42(2):91-106. PubMed ID: 22141324
[TBL] [Abstract][Full Text] [Related]
14. In vitro carcinogenicity testing: present and future perspectives in pharmaceutical development.
Kowalski LA
Curr Opin Drug Discov Devel; 2001 Jan; 4(1):29-35. PubMed ID: 11727320
[TBL] [Abstract][Full Text] [Related]
15. In vitro mammalian cell mutation assays based on transgenic reporters: A report of the International Workshop on Genotoxicity Testing (IWGT).
White PA; Luijten M; Mishima M; Cox JA; Hanna JN; Maertens RM; Zwart EP
Mutat Res Genet Toxicol Environ Mutagen; 2019 Nov; 847():403039. PubMed ID: 31699347
[TBL] [Abstract][Full Text] [Related]
16. [In vitro methods and safety testing of chemicals].
Louekari K; Salminen L; Tähti H
Duodecim; 1998; 114(9):851-8. PubMed ID: 11524804
[No Abstract] [Full Text] [Related]
17. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
[TBL] [Abstract][Full Text] [Related]
18. Contemporary trends in in vivo and in vitro testing of chemical carcinogens.
Slamenová D
Neoplasma; 2001; 48(6):425-34. PubMed ID: 11949832
[TBL] [Abstract][Full Text] [Related]
19. Effects of medicinal compounds on the differentiation of the eukaryotic microorganism dictyostelium discoideum: can this model be used as a screening test for reproductive toxicity in humans?
Dannat K; Tillner J; Winckler T; Weiss M; Eger K; Dingermann T
Pharmazie; 2003 Mar; 58(3):204-10. PubMed ID: 12685815
[TBL] [Abstract][Full Text] [Related]
20. A genotoxicity test system based on p53R2 gene expression in human cells: assessment of its reactivity to various classes of genotoxic chemicals.
Ohno K; Ishihata K; Tanaka-Azuma Y; Yamada T
Mutat Res; 2008 Oct; 656(1-2):27-35. PubMed ID: 18674635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
